LINC01269 and carcinoma of esophagus: Through pancancer analysis, we further confirmed that linc01269 was remarkably downregulated in HNSC and esophageal carcinoma (ESCA), while other malignancies remained unchanged (Figures 1(a) and 1(b), Figure S2A).